Pishvaian, M. J., Weiss, G. J., Falchook, G. S., Yee, N., Gil-Martin, M., Shahda, S., Moreno, V., Brana, I., Crittenden, M., Formenti, S., Al-Rajabi, R., Papadopoulos, K. P., Stankevich, E., Feng, M., Li, J., Mathias, M., Kroog, G., Lowy, I., & Fury, M. G. (n.d.). 1151PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort in a phase I study. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095485157.0x000034